A drug shortage is a quality failure with a body count.
Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.
By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.
The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.
| Drug | Company | Therapeutic area | Availability | Status | Posted |
|---|---|---|---|---|---|
| Dexmedetomidine Hydrochloride InjectionInjection | Accord Healthcare Inc. | Anesthesia | — | To Be Discontinued | 2026-04-21 |
| Ketorolac Tromethamine TabletTablet | Mylan Pharmaceuticals Inc., a Viatris Company | Analgesia/Addiction | — | To Be Discontinued | 2026-04-20 |
| Rifampin InjectionInjection | Sanofi-Aventis U.S. LLC | Anti-Infective | — | To Be Discontinued | 2026-04-20 |
| Tiagabine Hydrochloride TabletTablet | Teva Pharmaceuticals USA, Inc. | Neurology | — | To Be Discontinued | 2026-04-15 |
| Tiagabine Hydrochloride TabletTablet | Teva Pharmaceuticals USA, Inc. | Neurology | — | To Be Discontinued | 2026-04-15 |
| Tiagabine Hydrochloride TabletTablet | Teva Pharmaceuticals USA, Inc. | Neurology | — | To Be Discontinued | 2026-04-15 |
| Tiagabine Hydrochloride TabletTablet | Teva Pharmaceuticals USA, Inc. | Neurology | — | To Be Discontinued | 2026-04-15 |
| Nitroglycerin OintmentOintment | AbbVie Inc. | Analgesia/Addiction | — | To Be Discontinued | 2026-04-14 |
| Nitrofurantoin Oral SuspensionOral Suspension | Amneal Pharmaceuticals | Anti-Infective | — | To Be Discontinued | 2026-04-10 |
| Azithromycin TabletTablet | Pfizer Inc. | Anti-Infective | — | To Be Discontinued | 2026-04-09 |
| Azithromycin TabletTablet | Pfizer Inc. | Anti-Infective | — | To Be Discontinued | 2026-04-09 |
| Aprepitant Oral Powder for Suspension | Merck Sharp & Dohme LLC | Gastroenterology | — | To Be Discontinued | 2026-04-08 |
| Fosaprepitant Dimeglumine InjectionInjection | Fresenius Kabi USA, LLC | Gastroenterology | — | To Be Discontinued | 2026-04-08 |
| Idelalisib TabletTablet | Gilead Sciences, Inc. | Oncology | — | To Be Discontinued | 2026-04-07 |
| Idelalisib TabletTablet | Gilead Sciences, Inc. | Oncology | — | To Be Discontinued | 2026-04-07 |
| Ursodiol CapsuleCapsule | Strides Pharma Inc. | Other | — | To Be Discontinued | 2026-04-06 |
| Icosapent Ethyl CapsuleCapsule | Apotex Corp. | Cardiovascular | — | To Be Discontinued | 2026-04-01 |
| Icosapent Ethyl CapsuleCapsule | Apotex Corp. | Cardiovascular | — | To Be Discontinued | 2026-04-01 |
| Dapsone GelGel | Amneal Pharmaceuticals | Dermatology | — | To Be Discontinued | 2026-03-27 |
| Progesterone Vaginal GelVaginal Gel | AbbVie Inc. | Urology | — | To Be Discontinued | 2026-03-27 |
| Tazemetostat Hydrobromide TabletTablet | Epizyme, Inc. (An Ipsen Company) | Oncology | — | To Be Discontinued | 2026-03-27 |
| Lincomycin Hydrochloride InjectionInjection | XGen Pharmaceuticals DJB, Inc. | Anti-Infective | — | To Be Discontinued | 2026-03-26 |
| Clindamycin Palmitate Hydrochloride InjectionInjection | Amneal Pharmaceuticals | Anti-Infective | — | To Be Discontinued | 2026-03-26 |
| Lincomycin Hydrochloride InjectionInjection | XGen Pharmaceuticals DJB, Inc. | Anti-Infective | — | To Be Discontinued | 2026-03-26 |
| Nebivolol Hydrochloride TabletTablet | Torrent Pharmaceuticals Limited | Cardiovascular | — | To Be Discontinued | 2026-03-25 |
Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).